In transgenic mice exhibiting amyloidosis, BDNF gene administration post-disease onset reversed synaptic loss, partially normalized abnormal gene expression, enhanced cellular signaling, and restored learning and memory, independent of amyloid plaque load. Here, BDNF is linked to amyloidosis.